Your browser doesn't support javascript.
loading
Identification of two novel RHO mutations in Chinese retinitis pigmentosa patients.
Wang, Juan; Xu, Ding; Zhu, Tong; Zhou, Yue; Chen, Xin; Wang, Fang; Zhang, Jieping; Tian, Haibin; Gao, Furong; Zhang, Jingfa; Jin, Caixia; Xu, Jingying; Lu, Lixia; Liu, Qin; Xu, Guo-Tong.
Afiliação
  • Wang J; Department of Ophthalmology of Shanghai Tenth People's Hospital, and Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China; Department of Regenerative Medicine, Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, China.
  • Xu D; Department of Ophthalmology of Shanghai Tenth People's Hospital, and Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China.
  • Zhu T; Department of Regenerative Medicine, Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, China.
  • Zhou Y; Department of Regenerative Medicine, Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, China.
  • Chen X; Department of Regenerative Medicine, Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, China.
  • Wang F; Department of Ophthalmology of Shanghai Tenth People's Hospital, and Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China.
  • Zhang J; Department of Ophthalmology of Shanghai Tenth People's Hospital, and Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China; Department of Regenerative Medicine, Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, China.
  • Tian H; Department of Ophthalmology of Shanghai Tenth People's Hospital, and Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China; Department of Regenerative Medicine, Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, China.
  • Gao F; Department of Ophthalmology of Shanghai Tenth People's Hospital, and Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China; Department of Regenerative Medicine, Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, China.
  • Zhang J; Department of Ophthalmology of Shanghai Tenth People's Hospital, and Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China; Department of Ophthalmology, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
  • Jin C; Department of Ophthalmology of Shanghai Tenth People's Hospital, and Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China; Department of Regenerative Medicine, Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, China.
  • Xu J; Department of Ophthalmology of Shanghai Tenth People's Hospital, and Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China; Department of Regenerative Medicine, Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, China.
  • Lu L; Department of Ophthalmology of Shanghai Tenth People's Hospital, and Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China; Department of Regenerative Medicine, Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, China. Ele
  • Liu Q; Department of Ophthalmology, Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 02114, USA. Electronic address: qin_liu@meei.harvard.edu.
  • Xu GT; Department of Ophthalmology of Shanghai Tenth People's Hospital, and Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China; Department of Regenerative Medicine, Department of Pharmacology, and Stem Cell Research Center, Tongji University School of Medicine, Shanghai, China; The
Exp Eye Res ; 188: 107726, 2019 11.
Article em En | MEDLINE | ID: mdl-31319082
ABSTRACT
Retinitis pigmentosa (RP) is a group of genetically heterogeneous retinal diseases with more than 80 identified causative genes to date. Mutations in the RHO (rhodopsin, OMIM, 180380) are the most common cause of autosomal dominant RP (adRP) worldwide. RHO is also one of the few RP genes that can cause autosomal recessive RP (arRP). To explore the frequency of RP mutations in Chinese populations, panel-based NGS (next-generation sequencing) screening and Sanger sequencing validation were performed for RP patients from 72 unrelated Chinese families. Here we reported the identified mutations only in the RHO gene. Our results showed that 4 mutations in RHO were detected in 5 (6.94%) of the 72 RP families, including two known missense mutations, c.158C > G (p.P53R) and c.551A > C (p.Q184P), and two novel mutations, c.34delC (p.P12NA) and c.82C > T (p.Q28X). The c.34delC (p.P12NA) mutation was detected in heterozygous state in one patient with intermediate RP phenotype. The c.82C > T (p.Q28X) mutation was found in a homozygous state in one proband with advanced RP phenotype at the age of 32. Clinical examination of the heterozygous carriers of c.82C > T (p.Q28X) in that family showed that the father at the age of 60s experienced no symptoms of RP and normal fundus examinations but displayed reduced electroretinography (ERG) and abnormal visual field. The sister and brother at the age of 30s showed no typical aspects of RP phenotypes. Our results not only expand the mutation spectrum of the RHO gene, but also suggest that the 2 null mutations might play minor dominant effects, leading to less severe and slower retinal degeneration in heterozygous state and more severe phenotype in homozygous state.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rodopsina / Retinose Pigmentar / Povo Asiático / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Exp Eye Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rodopsina / Retinose Pigmentar / Povo Asiático / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Exp Eye Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China